Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of anisomycin in the preparation of drugs for the prevention/treatment of ovarian cancer

Anisomycin, ovarian cancer technology, applied in the directions of drug combination, antitumor drug, heterocyclic compound active ingredient, etc., can solve problems such as expression up-regulation, achieve the effect of great social benefit and good clinical application prospect

Active Publication Date: 2020-09-25
SHANGHAI GERIATRIC INST OF CHINESE MEDICINE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Guo et al. reported that after the intervention of anisomycin, the level of methyltransferase in SH-SY5Y cells decreased, and the promoters of three genes were demethylated, which led to the upregulation of the expression of APP, PS1 and BACE1

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of anisomycin in the preparation of drugs for the prevention/treatment of ovarian cancer
  • Application of anisomycin in the preparation of drugs for the prevention/treatment of ovarian cancer
  • Application of anisomycin in the preparation of drugs for the prevention/treatment of ovarian cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1 Isolation of tumor stem cells from patients with ovarian cancer

[0023] Seven patients with undifferentiated mixed epithelial ovarian cancer. The age, stage, degree of differentiation, and histological distribution of all ovarian cancer patient populations are shown in Table 1.

[0024] Isolation of tumor stem cells from ovarian cancer patients (7 ovarian cancer patients underwent surgery to remove ovarian cancer tissues. In this experiment, the excised tissues were collected in sterile centrifuge tubes, digested with 0.25% trypsin into a single-cell suspension, and each 100 μL Add 4 μL of CD44 and CD117 monoclonal antibodies (mouse anti-human CD117-FITC; rabbit anti-human CD44-PE, eBioscience) to the ovarian cancer cell suspension, and incubate the cells at 4°C for 30 minutes. Wash once with salt-buffered saline (PBS), and then use flow cytometry (BD FACS Aria, BD Bioscience, CA, USA) to separate CD44+ / CD117+ OCSCs cell subpopulation)

[0025] Table 1 Char...

Embodiment 2

[0028] Example 2 Anisomycin significantly inhibited the proliferation and invasion of OCSCs

[0029] MTT method (thiazolan method) to detect cell proliferation

[0030] Cells were seeded in (2×10 3 / ml) 96-well plate and at 37°C, 5% CO 2 Under the conditions, the cells were cultured with DMEM (modified high glucose cell medium) medium containing 10% FBS (fetal bovine serum) until 85% of the cells were confluent. MTT (3(V / V)-diphenylbromide; Sigma) reagent (5mg / ml) was added to the cell culture medium at different time points and incubated at 37°C for 4 hours. The reaction was terminated by adding 150 μL of dimethyl sulfoxide (DMSO, Sigma Chemicals) per well. The cells were lysed for 15 minutes, and the 96-well plate was shaken gently for 5 minutes. The absorbance value was determined by enzyme-linked immunosorbent assay (ELISA) at 490nm (model680, Bio-Rad Bole Biological Company).

[0031] Annexin V-FITC / PI (cell membrane phosphatidylserine-fluorescein isothiocyanate / prop...

Embodiment 3

[0038] Example 3 Anisomycin stimulates the expression of OCSCs apoptosis-related proteins and lncRNA BACE1-AS (long non-coding ribonucleic acid β decomposing enzyme translation nucleic acid sequence)

[0039] RNA extraction and analysis by qRT-PCR (real-time fluorescent quantitative polymerase chain reaction)

[0040] Total RNA was isolated from each cell using Trizol (Cell / Tissue Total RNA Extraction Buffer) reagent. RNA samples were treated with DNase I (Sigma-Aldrich) (type I deoxyribonucleolytic enzyme (Sigma Reagent Co., Ltd.)), and were treated with reverseraα (α-type ribonucleic acid reverse transcription) enzyme kit for first-strand cDNA synthesis (TOYOBO) Quantification and reverse transcription into cDNA. Real-time fluorescence quantitative RT-PCR adopts the realplex4 (fluorescence 4-color channel) real-time fluorescence quantitative RT-PCR detection system of Eppendorf Company (Germany), and uses SYBR green fluorescence quantitative PCR Master Mix (Toyobo) as the det...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of anisomycin to preparation of a medicine for preventing / treating ovarian cancer. The application is characterized in that the structural formula of the anisomycin is as follow: (the formula is as shown in the description); and the medicine is a medicinal composition consisting of the anisomycin serving as the active component, and medicinal auxiliary materials. The medicinal composition is an oral preparation or injection. The result of an experiment about the influence of the anisomycin on OCSCs (ovarian cancer stem cells) indicates that the anisomycin can obviously inhibit OCSCs proliferation and invasion. An experiment of stimulating OCSCs apoptosis related protein lncRNA BACE1-AS expression by the anisomycin is conducted, and data indicates that the anisomycin can induce high expression of starch-like-beta related protein of lncRNA BACE1-AS. Therefore, the anisomycin can be used for preparing the medicine for preventing / treating ovarian cancer. According to the application, a new medicine for preventing / treating ovarian cancer is provided, a good clinical application prospect is achieved and huge social benefits are achieved.

Description

technical field [0001] The invention relates to medicines, in particular to the application of anisomycin in the preparation of medicines for preventing / treating ovarian cancer. Background technique [0002] At present, it has been found that human ovarian cancer stem cells are the main reason for the resistance of ovarian cancer cells to chemotherapy drugs and the easy metastasis, recurrence and poor prognosis of ovarian cancer. However, the underlying mechanism of OCSCs (ovarian cancer stem cell) proliferation and erosion is still unclear, and there is no effective medical method to inhibit it. Fan et al reported that the overexpression of microRNA-20a can promote the proliferation and invasion of ovarian cancer cells by inhibiting the expression of amyloid precursor protein (Fan X, Liu Y, Jiang J, Ma Z, WuH, Liu T, Liu M, Li X and Tang H. miR-20a promotes proliferation and invASion bytargeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) 2010; 4...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/40A61P35/00
Inventor 刘特陈川郁志华王素魏黄永毅
Owner SHANGHAI GERIATRIC INST OF CHINESE MEDICINE